The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Interview with Fernando Cruzado, Vice President & Industry Lead Chemicals and Holger Peterkord, Senior Principal & Capex capability lead at Efeso Group
US paints and coatingsmaker PPG has agreed to sell its silicas products business for abou $310 million to Warsaw, Poland-based Qemetica, a manufacturer of soda ash...
Cannabis is a crop that has been cultivated for thousands of years and contains many pharmacologically active substances. In recent years, cannabis has become...
The Italian Association for the Study and Control of Contamination (ASCCA), in collaboration with the International Confederation of Contamination Control Societies...
December 2 - 5, 2024 | The 18th Annual GPCA Forum, the Gulf Petrochemicals and Chemicals Association (GPCA) flagship event, hosted by OQ, will take place for the first...
